July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...

LONDON, Aug 26 (Reuters) - French drugmaker Sanofi-Aventis will continue a legal battle in the United States against a generic version of its blood clot preventer Lovenox, despite a court rebuff, it ...

Momenta Pharmaceuticals Inc.'s surprising good fortune with the FDA's nod last week for the company's generic Lovenox sent shares skyrocketing 82 percent and capped five years of exchanges between the ...

Jerusalem, July 23, 2010 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) commented today on the U.S. Food and Drug Administration's response to a citizen petition questioning the approval ...

Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi-Aventis’ ...

Sanofi-Aventis said today it lost a patent infringement case against two generic drug makers involving its top-selling product, the blockbuster bloodthinner Lovenox. Amphastar Pharmaceuticals and Teva ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Lieff Cabraser is proud to announce that Momenta Pharmaceuticals, Inc. and Sandoz Inc. have agreed to settlements totaling $120 million in the antitrust class action ...

Zydus has signed a license and supply agreement with Chemi of Italy, a subsidiary of Italfarmaco Group, to launch the generic of Sanofi Aventis’s Lovenox (enoxaparin sodium injection) in seven dosage ...

NEW YORK/LONDON, Nov 6 (Reuters) - U.S. regulators have rejected Momenta Pharmaceuticals Inc's generic version of Sanofi-Aventis SA's top-selling thrombosis drug Lovenox, sending Momenta shares into a ...

Uninsured people who paid out of pocket for the anticoagulant drug Lovenox may be eligible for a payment from a $120 million proposed settlement in a dispute between Nashville General Hospital and two ...

DUBLIN--(BUSINESS WIRE)--The "Lovenox - Drug Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. 'Lovenox Drug Insight, 2018' highlights the drug marketed details and ...